Position in VRDN
as of Mar 31, 2026
· filed May 20, 2026
Position Value
$3,252,593
-$27,325,172 QoQ
Shares Held
166,288
-83.1% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vivo Capital, LLC holds $1,160,013,312 across 42 Biotechnology names. VRDN ranks #39 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
12,151,480 | $196,610,946 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
338,895 | $109,188,580 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
1,334,418 | $70,350,516 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $60,779,389 | |
| 5 | DBVT |
DBV Technologies S.A.
|
2,667,569 | $55,725,516 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
9,545,466 | $50,495,515 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,154,780 | $45,077,997 | |
| 8 | SABS |
SAB Biotherapeutics, Inc.
|
11,420,000 | $43,738,600 |
All Filings in VRDN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,252,593 | 166,288 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $30,577,765 | 982,576 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,203,990 | 982,576 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,736,412 | 982,576 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,245,124 | 982,576 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $18,835,981 | 982,576 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $38,179,209 | 1,678,207 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,833,473 | 1,678,207 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,385,404 | 1,678,207 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $36,551,348 | 1,678,207 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $25,743,695 | 1,678,207 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $39,924,544 | 1,678,207 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,693,586 | 1,678,207 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $49,020,426 | 1,678,207 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,046,989 | 1,660,019 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,041,000 | 1,300,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $24,037,000 | 1,300,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $25,701,000 | 1,300,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $21,385,000 | 1,300,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||